Intermittent Hypoxia and Caffeine in Infants Born Preterm
Public ClinicalTrials.gov record NCT03321734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Intermittent Hypoxia and Caffeine in Infants Born Preterm (ICAF)
Study identification
- NCT ID
- NCT03321734
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Children's National Research Institute
- Other
- Enrollment
- 170 participants
Conditions and interventions
Conditions
Interventions
- Caffeine Drug
- Placebos Drug
Drug
Eligibility (public fields only)
- Age range
- 32 Weeks to 36 Weeks
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 17, 2019
- Primary completion
- May 31, 2023
- Completion
- May 31, 2023
- Last update posted
- Aug 31, 2023
2019 – 2023
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Loma Linda University Health System | Loma Linda | California | 92354 | — |
| Children's National Medical Center/Children's Research Institute | Washington D.C. | District of Columbia | 20010 | — |
| AdventHealth Orlando | Orlando | Florida | 32803 | — |
| Johns Hopkins All Children's Hospital | St. Petersburg | Florida | 33701 | — |
| Kapiolani Medical Center | Honolulu | Hawaii | 96826 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| Johns Hopkins | Baltimore | Maryland | 21287 | — |
| Walter Reed National Military Medical Center | Bethesda | Maryland | 20889 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| University of Massachusetss | Worcester | Massachusetts | 01605 | — |
| University of Mississippi | Jackson | Mississippi | 39216 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03321734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2023 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03321734 live on ClinicalTrials.gov.